Germany's BfArM seeking new head
This article was originally published in Scrip
Executive Summary
Germany's medicines agency BfArM is seeking a new chair to succeed Professor Dr Walter Schwerdtfeger, who has reached retirement age and is due to leave at the end of July. Dr Schwerdtfeger, who has led BfArM since 2010, worked at the health ministry from 1992 to 2010, and before that was with the Paul-Ehrlich Institute. He is also vice-chair of the European Medicines Agency's management board.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.